Literature DB >> 26716603

Pricey pills for an even pricier problem.

Sharon W Kwan1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26716603      PMCID: PMC4815917          DOI: 10.1002/cncr.29854

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  13 in total

Review 1.  Epidemiology of viral hepatitis and hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

2.  Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.

Authors:  Elliot B Tapper; Andreea M Catana; Nidhi Sethi; Daniel Mansuri; Saurabh Sethi; Annie Vong; Nezam H Afdhal
Journal:  Cancer       Date:  2015-12-30       Impact factor: 6.860

3.  All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.

Authors:  Carrie McAdam-Marx; Lisa J McGarry; Christopher A Hane; Joseph Biskupiak; Baris Deniz; Diana I Brixner
Journal:  J Manag Care Pharm       Date:  2011-09

4.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.

Authors:  Scott Ramsey; David Blough; Anne Kirchhoff; Karma Kreizenbeck; Catherine Fedorenko; Kyle Snell; Polly Newcomb; William Hollingworth; Karen Overstreet
Journal:  Health Aff (Millwood)       Date:  2013-05-15       Impact factor: 6.301

5.  Cost of care for elderly cancer patients in the United States.

Authors:  K Robin Yabroff; Elizabeth B Lamont; Angela Mariotto; Joan L Warren; Marie Topor; Angela Meekins; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

6.  Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.

Authors:  Kris V Kowdley; Stuart C Gordon; K Rajender Reddy; Lorenzo Rossaro; David E Bernstein; Eric Lawitz; Mitchell L Shiffman; Eugene Schiff; Reem Ghalib; Michael Ryan; Vinod Rustgi; Mario Chojkier; Robert Herring; Adrian M Di Bisceglie; Paul J Pockros; G Mani Subramanian; Di An; Evguenia Svarovskaia; Robert H Hyland; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; David Pound; Michael W Fried
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

7.  Hidden morbidity in cancer: spouse caregivers.

Authors:  Michal Braun; Mario Mikulincer; Anne Rydall; Andrew Walsh; Gary Rodin
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

8.  Health care costs associated with hepatocellular carcinoma: a population-based study.

Authors:  Hla-Hla Thein; Wanrudee Isaranuwatchai; Michael A Campitelli; Jordan J Feld; Eric Yoshida; Morris Sherman; Jeffrey S Hoch; Stuart Peacock; Murray D Krahn; Craig C Earle
Journal:  Hepatology       Date:  2013-03-15       Impact factor: 17.425

9.  Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.

Authors:  Nezam Afdhal; K Rajender Reddy; David R Nelson; Eric Lawitz; Stuart C Gordon; Eugene Schiff; Ronald Nahass; Reem Ghalib; Norman Gitlin; Robert Herring; Jacob Lalezari; Ziad H Younes; Paul J Pockros; Adrian M Di Bisceglie; Sanjeev Arora; G Mani Subramanian; Yanni Zhu; Hadas Dvory-Sobol; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Mark Sulkowski; Paul Kwo
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

10.  Chronic hepatitis C virus (HCV) disease burden and cost in the United States.

Authors:  Homie Razavi; Antoine C Elkhoury; Elamin Elbasha; Chris Estes; Ken Pasini; Thierry Poynard; Ritesh Kumar
Journal:  Hepatology       Date:  2013-05-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.